![Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy](https://pub.mdpi-res.com/cells/cells-09-00802/article_deploy/html/images/cells-09-00802-g001.png?1612336034)
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
![CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4314fe212f09142cbdf4b8e2141b1bc761f12601/5-Figure3-1.png)
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar
![Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases](https://www.frontiersin.org/files/Articles/463666/fimmu-10-01187-HTML-r1/image_m/fimmu-10-01187-g001.jpg)
Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
![Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease:](https://jitc.bmj.com/content/jitc/8/1/e000630/F2.large.jpg)
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease:
![Plastic CD34 and CD38 expression in adult B–cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations | Leukemia Plastic CD34 and CD38 expression in adult B–cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2016.315/MediaObjects/41375_2017_Article_BFleu2016315_Fig1_HTML.jpg)
Plastic CD34 and CD38 expression in adult B–cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations | Leukemia
![Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review](https://media.biocompare.com/m/37/article/178287/pd-1%20&%20cd38%20co-expression.jpg)
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
![Expanding anti-CD38 immunotherapy for lymphoid malignancies | Journal of Experimental & Clinical Cancer Research | Full Text Expanding anti-CD38 immunotherapy for lymphoid malignancies | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02421-2/MediaObjects/13046_2022_2421_Fig2_HTML.png)
Expanding anti-CD38 immunotherapy for lymphoid malignancies | Journal of Experimental & Clinical Cancer Research | Full Text
![A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma | Journal of Hematology & Oncology | Full Text A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01171-6/MediaObjects/13045_2021_1171_Fig1_HTML.png)
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma | Journal of Hematology & Oncology | Full Text
![Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents](https://pub.mdpi-res.com/cells/cells-08-01632/article_deploy/html/images/cells-08-01632-g001.png?1577743403)